VANCOUVER, British Columbia, July 17, 2019 /PRNewswire/ -- MYM Nutraceuticals Inc., (CSE: MYM) (CSE: MYM.CN) (OTCBB: MYMMF) ("MYM" or "The Company") announces it has closed the second tranche of its non-brokered private placement announced on July 5, 2019 of 2,528,174 units at a price of $0.324 for gro

VANCOUVER, July 17, 2019 /PRNewswire/ - Choom™ (CSE: CHOO; OTCQB: CHOOF), is pleased to announce that, pursuant a convertible debenture issued to Choom by Coastal Green Holdings Ltd., Choom will, on conversion of the debenture, acquire a 19.9% equity interest in Coastal Green.

HOUSTON, July 17, 2019 /PRNewswire/ --

PALO ALTO, Calif., July 17, 2019 /PRNewswire/ -- HGGC, a leading middle-market private equity firm, today announced it has agreed to the sale of a minority stake in Nutraceutical International Corporation—a vertically integrated manufacturer, marketer, and distributor of branded nutritional supplements, personal care, and other natural products—to Snapdragon

CAMBRIDGE, Mass., July 17, 2019 /PRNewswire/ -- EIP Pharma, Inc., a CNS-focused therapeutics company, today announced that new preclinical data regarding neflamapimod were presented at the AAIC 2019 scientific meeting in Los Angeles, CA (July 14-18, 2019). 

BILLERICA, Mass., July 17, 2019 /PRNewswire/ -- Bruker Corporation (Nasdaq: BRKR) has been advised that former board member, Mr. Joerg C. Laukien, has authorized a block sale of Bruker shares as part of his retirement planning and portfolio diversification.  Joerg Laukien retired from the Bruker board of

SAN JOSE, Calif., July 17, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today an

SECAUCUS, N.J. and ROCKVILLE CENTRE, N.Y., July 17, 2019 /PRNewswire/ -- Catholic Health Services (CHS), an integrated health care delivery system with a 24% market share on Long Island, is teaming up with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services,

MADISON, Wis., July 17, 2019 /PRNewswire/ -- The more than 2,400 people of Exact Sciences work every day to create life-changing innovations in earlier cancer detection. In the process, they also created a certifiably great place to work.

LAS VEGAS, July 17, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX), through its subsidiary, GBS Global Biopharma, Inc. ("GBS", Ottawa, CANADA), has filed a novel patent application to protect proprietary formulations for chronic pain based on new molecular docking simulations and functional assay data. New pain treatments are a vita